Agaoglu Leyla, Torun Oktay, Unuvar Emin, Sefil Yasemin, Demir Dilek
Department of Pediatrics, Istanbul Faculty of Medicine, Istanbul University, Capa, Istanbul, Turkey.
Arzneimittelforschung. 2007;57(6A):426-30. doi: 10.1055/s-0031-1296691.
To examine the effects of iron deficiency anemia on cognitive function and intelligence in children.
Matched case-control study was carried out with 30 children (aged 6-12 years) with iron deficiency anemia (IDA) but without any chronic disease and with normal neuromotor development. The WISC-R intelligence test was performed before and after 4-6 months of iron/vitamin treatment (5 mg iron/kg/day as iron(III)-hydroxide polymaltose complex, IPC, and multivitamin preparation). Pre- and post-treatment IQ scores of the IDA group were evaluated and compared to the control group.
Treatment and control groups were similar in terms of age and gender (mean age 9.1 +/- 1.9 years for IDA group, 8.8 +/- 1.5 years for controls, 37 % versus 40 % girls, respectively). Mean total IQ score of the IDA group was 12.9 points lower than that of the control group and this was statistically significant (p < 0.01). Although a highly significant increase of 4.8 points in total IQ was found after treatment with IPC in the IDA group (p < 0.01), post-treatment mean total IQ score of the IDA group was 8.2 points lower than that of the control group. However this difference of 8.2 points was not statistically significant (p > 0.05). There were significant differences in the subtests of WISC-R between the pre-treatment IDA group and the control group. A significant improvement was found especially in these subtests following treatment.
Iron deficiency anemia in children can affect long-term cognitive function. The WISC-R intelligence test subsets and pre- and post-treatment IQ scores of the IDA group were significantly differing from control group.
探讨缺铁性贫血对儿童认知功能和智力的影响。
对30名6至12岁缺铁性贫血(IDA)但无任何慢性病且神经运动发育正常的儿童进行配对病例对照研究。在进行铁/维生素治疗(5毫克铁/千克/天,以氢氧化铁聚麦芽糖复合物,IPC,和多种维生素制剂)4至6个月前后进行韦氏儿童智力量表修订版(WISC-R)智力测试。评估IDA组治疗前后的智商得分并与对照组进行比较。
治疗组和对照组在年龄和性别方面相似(IDA组平均年龄9.1±1.9岁,对照组8.8±1.5岁,女孩分别为37%和40%)。IDA组的平均总智商得分比对照组低12.9分,这具有统计学意义(p<0.01)。尽管IDA组用IPC治疗后总智商显著提高了4.8分(p<0.01),但IDA组治疗后的平均总智商得分仍比对照组低8.2分。然而,这8.2分的差异无统计学意义(p>0.05)。治疗前IDA组和对照组在WISC-R的子测试中有显著差异。治疗后尤其是这些子测试中有显著改善。
儿童缺铁性贫血会影响长期认知功能。IDA组的WISC-R智力测试子集以及治疗前后的智商得分与对照组有显著差异。